Tango Therapeutics Inc <TNGX.OQ> expected to post a loss of 35 cents a share - Earnings Preview
Tango Therapeutics Inc TNGX.OQ TNGX.O is expected to show a fall in quarterly revenue when it reports results on August 5 for the period ending June 30 2025
The Boston Massachusetts-based company is expected to report a 66.4% decrease in revenue to $6.679 million from $19.88 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Tango Therapeutics Inc is for a loss of 35 cents per share.
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Tango Therapeutics Inc is $9.50, about 36.4% above its last closing price of $6.04
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.34 | -0.35 | -0.36 | Missed | -2.9 |
Dec. 31 2025 | -0.33 | -0.34 | -0.35 | Missed | -3.3 |
Sep. 30 2024 | -0.35 | -0.37 | -0.27 | Beat | 26.5 |
Jun. 30 2024 | -0.35 | -0.34 | -0.24 | Beat | 30.4 |
Mar. 31 2024 | -0.31 | -0.31 | -0.35 | Missed | -11.9 |
Dec. 31 2023 | -0.30 | -0.28 | -0.32 | Missed | -15.2 |
Sep. 30 2023 | -0.34 | -0.34 | -0.23 | Beat | 33.3 |
Jun. 30 2023 | -0.31 | -0.34 | -0.23 | Beat | 31.5 |
This summary was machine generated August 1 at 14:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Amazon Q2 FY2025 Earnings Review: Robust Cloud and AI Growth Coupled with Retail Tariff Challenges
TradingKey - Amazon.com, Inc. (NASDAQ: AMZN) released its Q2 FY2025 earnings on July 31, 2025, after market close, delivering results that surpassed expectations, driven by robust growth in AWS, advertising, and retail segments.
U.S. GDP, PCE, and Fed Rate Decision Commentary: Will U.S. Stocks Continue to Rise?
TradingKey - On 30–31 July 2025, the United States released its latest GDP and PCE data, while the Federal Reserve announced its interest rate decision during the same period.
Berkshire Hathaway FY2025 Second Quarter Earnings Preview
TradingKey - The Q2 2025 earnings report for Berkshire Hathaway is expected to be released on August 2. Below are the market expectations for Berkshire Hathaway’s Q2 2025 revenue and earnings per share (EPS):
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics..jpg)
